In defense of ILNS. I do not like the r/s anymore than any one else. On Friday, I took a loss when I sold my shares just like most people. However, we must remember two key facts. 1) We were told a r/s was coming. It was clearly stated in the February 2011 10-Q, page 13. I got out of ILNS several weeks ago because I feared that the r/s was coming. I got back in recently with a modest investment when it did not happen and I was afraid the stock would leave the train station without me. So I got back in with a small investment just in time for the r/s. We were warned! 2) Correct me if I am wrong: But I have tried to find out how many times ILNS has done a r/s. My info goes back to 2006 and since 2006 this is the only r/s ILNS has done! That is not a bad record at all. Some small pharmaceuticals do a r/s over and over. Not true with ILNS! In fact, this may be the first r/s for ILNS. I am not sure. It would be interesting if anyone could find out. Since the company was founded how many r/s have they done? Clearly, their record since 2006 for r/s is a good one. Now that the r/s is done, I can't wait to get back in once the post r/s pps settles down. I can now invest in ILNS with more confidence than ever. True, there will be common stock dilution in ILNS but that is manageable. Almost all small pharmaceuticals must engage in common stock dilution. We all know this about small pharmaceuticals and accept the risks. However, it is the r/s that is the real killer for investors. Thankfully that is now behind us. In any case, I expect to make 500%+ on my investment in ILNS by December of this year! Good luck to all.
AI
Market Data 
Markets 
